Emil Chuang

Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

Steven R. Smith, Neil J. Weissman, Christen M. Anderson et al. · New England Journal of Medicine · 2010 · 912 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Potent Reduction of Apolipoprotein B and Low-Density Lipoprotein Cholesterol by Short-Term Administration of an Antisense Inhibitor of Apolipoprotein B

John J.P. Kastelein, Mark K. Wedel, Brenda F. Baker et al. · Circulation · 2006 · 357 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes.

Barbara Haber, S Chin, Emil Chuang et al. · Journal of Clinical Investigation · 1995 · 139 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Combined Serological, Genetic, and Inflammatory Markers Differentiate Non-IBD, Crohnʼs Disease, and Ulcerative Colitis Patients

Scott E. Plevy, Mark S. Silverberg, S. Lockton et al. · Inflammatory Bowel Diseases · 2013 · 126 citations · Full text

Life Sciences, Bioinformatics, Immunology +17

A Phase II dose ranging, double‐blind, placebo‐controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left‐sided ulcerative colitis

Sander J. H. van Deventer, Mark K. Wedel, Brenda F. Baker et al. · Alimentary Pharmacology & Therapeutics · 2006 · 126 citations

Nursing, Pharmacology, Pharmacotherapy +17